{
    "clinical_study": {
        "@rank": "112676", 
        "arm_group": [
            {
                "arm_group_label": "Goal A", 
                "arm_group_type": "Active Comparator", 
                "description": "controled fluid therapy: 5~10ml/kg/hr fulfillment of two or more of four criteria:\nheart rate <120 beats/min,\nmean  arterial blood pressure 65-85 mm Hg,\nurine output  \u22651  ml/kg /h\nHematocrit  \u226435%."
            }, 
            {
                "arm_group_label": "Goal B", 
                "arm_group_type": "Other", 
                "description": "controled fluid therapy: 5~10ml/kg/hr fulfillment of all of the following criteria:\n1 central venous pressure8-12 mmHg , 2.mean arterial pressure 65-85 mm Hg, 3. urine output  \u22650.5 ml/kg/h 4. ScvO2 \u226470%"
            }
        ], 
        "brief_summary": {
            "textblock": "To compare different goals of fluid resuscitation in early stage of acute pancreatitis"
        }, 
        "brief_title": "Fluid Resuscitation Goal in Early Stage of Severe Acute Pancreatitis", 
        "completion_date": {
            "#text": "August 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Pancreatitis", 
        "condition_browse": {
            "mesh_term": "Pancreatitis"
        }, 
        "detailed_description": {
            "textblock": "With regard to study of sepsis and several studies of SAP demonstrating the deleterious\n      effects of fluid loss and haemoconcentration within the first 24h after admission\uff08or onset\n      of abdominal pain\uff09, early goal-directed fluid resuscitation has the potential of improving\n      outcome also in SAP. But the goal of fluid resuscitation remained controversial.Several\n      criteria of fluid resuscitation had been described. Ours had been described in previous\n      study, and had shown a ideal result with less incidence of abdominal compartment syndrome\n      and higher survival rate. This study aims to determine a better goal of fluid resuscitation\n      in severe acute pancreatitis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1. Diagnosis of pancreatitis: Typical pain increase in serum lipase or amylase 2.\n             Onset of abdominal pain within <=72h before admission 3. moderate severe or severe\n             acute pancreatitis according to Atlanta criteria revisited in 2012 4. Evidence of >=\n             1 predictor of fluid resuscitation: Haematocrit >44% (male) or >40% (female),\n             respectively Lactate>4mmol/L; heart rate>120bpm; urine <0.5ml/kg/h for 6 hour; Mean\n             arterial pressure>85 or <60 mmHg\n\n        Exclusion Criteria:\n\n          -  1. Pregnancy 2. New York Heart Association classification >II 3. With pacemaker\n             implantation 4. chronic obstructive pulmonary disease 5. chronic kidney disease 6.\n             Pre-existing disease with life expectancy < 3 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01974466", 
            "org_study_id": "RJpancreatitis01", 
            "secondary_id": "RJpancreatitis01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Goal A", 
                "description": "controled fluid therapy\uff1a10~5ml/kg/h\uff0ccrystalloid vs colloid 2:1 resuscitation target\uff1a fulfillment of two or more of four criteria:1. HR <120 beats/min, 2.MAP 65-85 mm Hg, 3. urine output  \u22651  ml/kg /h    4. HCT  \u226435%.", 
                "intervention_name": "Goal A", 
                "intervention_type": "Other", 
                "other_name": "Ruijin pancreatitis goal"
            }, 
            {
                "arm_group_label": "Goal B", 
                "description": "controled fluid therapy\uff1a10~5ml/kg/h\uff0ccrystalloid vs colloid 2:1 resuscitation target\uff1a fulfillment of all of the following criteria:\n1 CVP 8-12 mmHg , 2.MAP 65-85 mm Hg, 3. urine output \u22650.5 ml/kg/h 4. ScvO2 \u226470%", 
                "intervention_name": "Goal B", 
                "intervention_type": "Other", 
                "other_name": "Sepsis goal"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "pancreatitis", 
            "resuscitation goal"
        ], 
        "lastchanged_date": "November 18, 2013", 
        "location": {
            "contact": {
                "email": "clockming@live.com", 
                "last_name": "zhen er chen, PhD", 
                "phone": "64370045", 
                "phone_ext": "665570"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "20000"
                }, 
                "name": "Ruijin"
            }, 
            "investigator": {
                "last_name": "Zhen er chen, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Fluid Resuscitation Goal in Early Stage of Severe Acute Pancreatitis", 
        "other_outcome": {
            "measure": "respiratory failure", 
            "safety_issue": "Yes", 
            "time_frame": "14days"
        }, 
        "overall_contact": {
            "email": "chenerzhen@hotmail.com", 
            "last_name": "Zhen er Chen, PhD", 
            "phone": "64370045", 
            "phone_ext": "665520"
        }, 
        "overall_official": [
            {
                "affiliation": "Emergency intensive care unit of Ruijin Hospital", 
                "last_name": "Qiang En Mao, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "doctor", 
                "last_name": "Ming zhong, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Science and Technology Commission of Shanghai Municipality", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Mortality", 
            "safety_issue": "Yes", 
            "time_frame": "28day"
        }, 
        "reference": {
            "PMID": "19187641", 
            "citation": "Mao EQ, Tang YQ, Fei J, Qin S, Wu J, Li L, Min D, Zhang SD. Fluid therapy for severe acute pancreatitis in acute response stage. Chin Med J (Engl). 2009 Jan 20;122(2):169-73."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01974466"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ruijin Hospital", 
            "investigator_full_name": "Erzhen Chen", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "intra-abdominal Hypertension", 
            "safety_issue": "Yes", 
            "time_frame": "7 days"
        }, 
        "source": "Ruijin Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "RenJi Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Ruijin Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}